Pharmacoeconomics (eBook, ePUB)
From Theory to Practice
Redaktion: Arnold, Renee J. G.
47,95 €
47,95 €
inkl. MwSt.
Sofort per Download lieferbar
24 °P sammeln
47,95 €
Als Download kaufen
47,95 €
inkl. MwSt.
Sofort per Download lieferbar
24 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
47,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
24 °P sammeln
Pharmacoeconomics (eBook, ePUB)
From Theory to Practice
Redaktion: Arnold, Renee J. G.
- Format: ePub
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Pharmacoeconomics: From Theory to Practice, Second Edition focuses on how to save money, not by restricting access to necessary medical services, but by using available resources more efficiently and rationally.
- Geräte: eReader
- ohne Kopierschutz
- eBook Hilfe
- Größe: 5.03MB
Andere Kunden interessierten sich auch für
- Pharmacoeconomics (eBook, PDF)47,95 €
- Vikas BajpaiPhytochemistry of Piper betle Landraces (eBook, ePUB)60,95 €
- Vikas BajpaiPhytochemistry of Piper betle Landraces (eBook, PDF)60,95 €
- Finlay MacritchieScientific Research as a Career (eBook, ePUB)47,95 €
- Monika Maya WahiAnalyzing Health Data in R for SAS Users (eBook, ePUB)47,95 €
- Mickey C. SmithPrinciples of Pharmaceutical Marketing (eBook, ePUB)41,95 €
- Physical Activity and Health (eBook, ePUB)57,95 €
-
-
-
Pharmacoeconomics: From Theory to Practice, Second Edition focuses on how to save money, not by restricting access to necessary medical services, but by using available resources more efficiently and rationally.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Taylor & Francis
- Seitenzahl: 334
- Erscheinungstermin: 5. August 2020
- Englisch
- ISBN-13: 9780429957673
- Artikelnr.: 59949143
- Verlag: Taylor & Francis
- Seitenzahl: 334
- Erscheinungstermin: 5. August 2020
- Englisch
- ISBN-13: 9780429957673
- Artikelnr.: 59949143
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
Dr. Renée J. Goldberg Arnold completed her undergraduate training at the University of Maryland and received her Doctor of Clinical Pharmacy degree from the University of Southern California in Los Angeles. She also completed a one-year post-doctoral residency at University Hospital in San Diego, which is affiliated with the University of California at San Francisco School of Pharmacy. She is currently President and CEO of Arnold Consultancy & Technology LLC, as well as Adjunct Associate Professor, Department of Environmental Medicine and Public Health, Master of Public Health program, Icahn School of Medicine at Mount Sinai in New York City, where she developed and teaches the Pharmacoeconomics coursework. Her special interest in evidence-based health derives from her research that deals with use of technology to collect and/or model real-world data for use in rational decision-making by healthcare practitioners and policy makers. Dr. Arnold was previously Vice President, Health Economics and Outcomes Research at Quorum Consulting, Inc./Navigant Consulting; Principal, IMS Health (IQVIA); and President and Co-Founder of Pharmacon International, Inc. Center for Health Outcomes Excellence. She is a founding member and former Chair of the Education Committee of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Currently, she Chairs both the ISPOR Distance Learning Program and the newly developed Open Source Models Special Interest Group. She is an author/co-author of numerous articles, book chapters and books in the areas of pharmacology, pharmacoeconomics and cost containment strategies. She is also a Reviewer for National Institutes of Health Small Business Innovation Research (SBIR) applications, for Patient-Centered Outcomes Research Institute (PCORI) applications, for the Pharmacoeconomics, Journal of Managed Care Pharmacy, Value in Health, American Journal of Pharmacy Benefits, Nature Biotechnology and Annals of Internal Medicine journals and is on the editorial board of Pharmacoeconomics Open. She is also a volunteer for the Medical Reserve Corps in New York City. In addition, Dr. Arnold is a licensed pharmacist.
Introduction to Pharmacoeconomics
Decision Modeling Techniques
Multiple Criteria Decision Analysis (MCDA)
Cost of Illness
Markov Modeling in Decision Analysis
Novel Modeling Methods (DICE)
Retrospective Database Analysis
What is Cost-Minimization Analysis?
Cost-Effectiveness Analysis
Budget Impact Analysis
Cost-Utility Analysis: A Case Study of a Quadrivalent Human Papillomavirus Vaccine
Some Problems/Assumptions in Pharmacoeconomic Analysis
Patient-Reported Outcome Measures
Sensitivity Analysis
Use of Pharmacoeconomics in Drug Reimbursement in Australia, Canada, and the United Kingdom: What Can We Learn from International Experience?
Implementation of Value Frameworks in Reimbursement Decisions in the US and Beyond, NICE (UK) and PBAC (Australia
Pharmacoeconomics in Disease Management: Practical Applications and Persistent Challenges
Computer Aided Decision Making from Drug Discovery to Pharmacoeconomics
Speculations on the Future Challenges and Value of Pharmacoeconomics.
Decision Modeling Techniques
Multiple Criteria Decision Analysis (MCDA)
Cost of Illness
Markov Modeling in Decision Analysis
Novel Modeling Methods (DICE)
Retrospective Database Analysis
What is Cost-Minimization Analysis?
Cost-Effectiveness Analysis
Budget Impact Analysis
Cost-Utility Analysis: A Case Study of a Quadrivalent Human Papillomavirus Vaccine
Some Problems/Assumptions in Pharmacoeconomic Analysis
Patient-Reported Outcome Measures
Sensitivity Analysis
Use of Pharmacoeconomics in Drug Reimbursement in Australia, Canada, and the United Kingdom: What Can We Learn from International Experience?
Implementation of Value Frameworks in Reimbursement Decisions in the US and Beyond, NICE (UK) and PBAC (Australia
Pharmacoeconomics in Disease Management: Practical Applications and Persistent Challenges
Computer Aided Decision Making from Drug Discovery to Pharmacoeconomics
Speculations on the Future Challenges and Value of Pharmacoeconomics.
Introduction to Pharmacoeconomics
Decision Modeling Techniques
Multiple Criteria Decision Analysis (MCDA)
Cost of Illness
Markov Modeling in Decision Analysis
Novel Modeling Methods (DICE)
Retrospective Database Analysis
What is Cost-Minimization Analysis?
Cost-Effectiveness Analysis
Budget Impact Analysis
Cost-Utility Analysis: A Case Study of a Quadrivalent Human Papillomavirus Vaccine
Some Problems/Assumptions in Pharmacoeconomic Analysis
Patient-Reported Outcome Measures
Sensitivity Analysis
Use of Pharmacoeconomics in Drug Reimbursement in Australia, Canada, and the United Kingdom: What Can We Learn from International Experience?
Implementation of Value Frameworks in Reimbursement Decisions in the US and Beyond, NICE (UK) and PBAC (Australia
Pharmacoeconomics in Disease Management: Practical Applications and Persistent Challenges
Computer Aided Decision Making from Drug Discovery to Pharmacoeconomics
Speculations on the Future Challenges and Value of Pharmacoeconomics.
Decision Modeling Techniques
Multiple Criteria Decision Analysis (MCDA)
Cost of Illness
Markov Modeling in Decision Analysis
Novel Modeling Methods (DICE)
Retrospective Database Analysis
What is Cost-Minimization Analysis?
Cost-Effectiveness Analysis
Budget Impact Analysis
Cost-Utility Analysis: A Case Study of a Quadrivalent Human Papillomavirus Vaccine
Some Problems/Assumptions in Pharmacoeconomic Analysis
Patient-Reported Outcome Measures
Sensitivity Analysis
Use of Pharmacoeconomics in Drug Reimbursement in Australia, Canada, and the United Kingdom: What Can We Learn from International Experience?
Implementation of Value Frameworks in Reimbursement Decisions in the US and Beyond, NICE (UK) and PBAC (Australia
Pharmacoeconomics in Disease Management: Practical Applications and Persistent Challenges
Computer Aided Decision Making from Drug Discovery to Pharmacoeconomics
Speculations on the Future Challenges and Value of Pharmacoeconomics.